NPI: 1093782658 · ARCADIA, FL 34266 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,847 | $1.39M |
| 2019 | 11,262 | $2.91M |
| 2020 | 12,241 | $2.36M |
| 2021 | 12,886 | $1.82M |
| 2022 | 9,095 | $1.47M |
| 2023 | 2,436 | $165K |
| 2024 | 1,671 | $99K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 19,639 | 1,387 | $3.37M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,462 | 811 | $3.24M |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,374 | 734 | $1.90M |
| A4657 | Syringe, with or without needle, each | 1,795 | 822 | $509K |
| J1756 | Injection, iron sucrose, 1 mg | 3,001 | 606 | $366K |
| 85048 | 803 | 612 | $169K | |
| 85041 | 803 | 612 | $169K | |
| 82728 | 610 | 457 | $125K | |
| 83550 | 629 | 465 | $121K | |
| 83540 | 629 | 465 | $121K | |
| 83970 | 291 | 228 | $63K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 342 | 215 | $56K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 26 | 25 | $6K |
| 90674 | 18 | 14 | $4K | |
| G0008 | Administration of influenza virus vaccine | 16 | 13 | $4K |